Australian Clinical Labs Quote - ACL | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
Australia
ASX
Australian Clinical Labs Limited (ACL) Share Price

Australian Clinical Labs Limited (ACL)

3.57

-0.09

(-2.46%)

Closed September 27 1:00AM

Delayed by 20 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

3.57

Bid

3.55

Ask

3.58

Volume

870,128

3.53 Day's Range 3.69

2.14 52 Week Range 3.69

Market Cap

Previous Close

3.66

Open

3.63

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

1,334,063

Shares Outstanding

201,834,015

Dividend Yield

-

PE Ratio

30.10

Earnings Per Share (EPS)

0.12

Revenue

697.54M

Net Profit

23.93M

Sector

Medical Laboratories

Industry

Medical Laboratories

Website

clinicallabs.com.au/offer

Headquarters

Melbourne, Victoria, Aus

Founded

-

Australian Clinical Labs Limited is listed in the Medical Laboratories sector of the Australian Stock Exchange with ticker ACL. The last closing price for Australian Clinical Labs was AUD3.66. Over the last year, Australian Clinical Labs shares have traded in a share price range of AUD 2.14 to AUD 3.69.

Australian Clinical Labs currently has 201,834,015 shares outstanding. The market capitalization of Australian Clinical Labs is AUD738.71 million. Australian Clinical Labs has a price to earnings ratio (PE ratio) of 30.10.

Alchemia Limited slammed 53%: Is the stock a buy?

http://www.fool.com.au/2015/05/29/alchemia-limited-slammed-53-is-the-stock-a-buy/

Alchemia Announces Initiation of Phase II Trial in Small Cell Lung Cancer

Alchemia Limited (ASX:ACL), today announced the initiation of recruitment for a Phase II clinical study of its lead cancer drug HA-Irinotecan in Small Cell Lung Cancer (SCLC...

UPDATE: Dr Reddy's Gets US OK For Generic Anticlotting Injection

Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday it has received U.S. regulatory approval to launch a copy of GlaxoSmithKline PLC's (GSK) anticlotting Arixtra injection, which is expected...

Dr. Reddy’s Announces the USFDA Approval of Fondaparinux Sodium Injection

Dr. Reddy’s Laboratories (NYSE: RDY) and Alchemia Limited, Brisbane, Australia (ASX: ACL) announced today that Dr. Reddy’s has received final approval of Dr. Reddy’s ANDA for...

Dr Reddy's Gets US OK To Sell Generic Injection To Prevent Blood Clots

Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday it has received final approval from the U.S. Food and Drug Administration to sell a generic version of GlaxoSmithKline PLC's (GSK) Arixtra...

Alchemia to Present at Cowen and Company 31st Annual Health Care Conference

Alchemia Limited (ASX: ACL) announced today that Pete Smith, Chief Executive Officer, is scheduled to present a corporate update at the Cowen and Company 31st Annual Health Care...

Alchemia and Dr Reddy’s Expand Fondaparinux Marketing Collaboration

Alchemia (ASX:ACL) today announced the agreement of terms with Dr Reddy’s Limited for marketing fondaparinux sodium for injection (the generic version of GlaxoSmithKline’s...

Alchemia’s HyACT Technology Enhances the Killing of Cancer Stem Cell Populations in Breast and Colorectal Cancer

Alchemia’s (ASX: ACL) subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research (AACR) 101st Annual Meeting in Washington, DC. The...

Emisphere Technologies and Alchemia to Research an Oral Formulation of Fondaparinux with Eligen® Technology

Emisphere Technologies, Inc. (OTCBB:EMIS) and Alchemia Ltd. (ASX:ACL) today announced that they are joining efforts to develop an oral formulation of the anti-coagulant drug...

CORRECT: Alcon 3Q Profit Down 18%, Raises 2009 Earnings View

("Alcon 3Q Profit Down 18%, Raises 2009 Earnings View 2nd Time," published at 6:12 p.m. EDT, incorrectly included a tax benefit for the latest quarter. The correct version follows.) DOW JONES...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.02	0.56338028169	3.55	3.69	3.46	1847921	3.55389782	DE
4	0.67	23.1034482759	2.9	3.69	2.88	1753462	3.34327626	DE
12	1.1	44.5344129555	2.47	3.69	2.25	1334063	2.8538654	DE
26	0.93	35.2272727273	2.64	3.69	2.14	932481	2.71044624	DE
52	0.75	26.5957446809	2.82	3.69	2.14	684904	2.7171334	DE
156	-1.02	-22.2222222222	4.59	6.39	2.14	700710	3.63121267	DE
260	3.559	32354.5454545	0.011	6.39	0.011	699874	3.65839706	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ACMOAAustralian Critical Minerals Ltd	AUD 0.025 (150.00%)	60k
MTBMount Burgess Mining Nl	AUD 0.002 (100.00%)	1.85M
AUZOBAustralian Mines Ltd	AUD 0.002 (100.00%)	350k
DOUDouugh Limited	AUD 0.005 (66.67%)	30.32M
4DXO4DMedical Limited	AUD 0.065 (62.50%)	932.32k
SGRStar Entertainment Group Limited	AUD 0.265 (-84.86%)	313.22M
MPPMetro Performance Glass Limited	AUD 0.04 (-52.94%)	258.38k
PAROParadigm Biopharmaceuticals Limited	AUD 0.006 (-33.33%)	20.15k
NHEONoble Helium Ltd	AUD 0.004 (-33.33%)	21k
1TTThrive Tribe Technologies Ltd	AUD 0.001 (-33.33%)	15M
SGRStar Entertainment Group Limited	AUD 0.265 (-84.86%)	313.22M
SYASayona Mining Limited	AUD 0.031 (8.77%)	128.59M
PVTPivotal Metals Ltd	AUD 0.012 (0.00%)	107.79M
IMUImugene Limited	AUD 0.049 (0.00%)	47.86M
PLSPilbara Minerals Limited	AUD 3.16 (6.04%)	37.52M

louieforpar

louieforpar 2 minutes ago

Speaking of lies. Doesn’t everyone that is innocent settle their case?Here’s your Newsmax case.

“Newsmax is pleased to announce it has resolved the litigation brought by Smartmatic through a confidential settlement,” the network said in a statement.”

“L

oystersnbeer

oystersnbeer 2 minutes ago

Broken Man

https://youtu.be/U7ZSKGN0plE?feature=shared

moola26

moola26 2 minutes ago

Happy Friday shareholders.
Why does it bother non shareholders that we hold shares?
Why do they have to respond to every post?
Why do they monitor a board 24/7 they hold zero shares in ?
Why does it upset them that shareholders post on this board ?
Holding with

ChannelTrader

ChannelTrader 4 minutes ago

Where Is Nathan Wade? Authorities Search for Fani Willis’ Lover After Missing House Judiciary Committee Hearing

https://truthpress.com/news/where-is-nathan-wade-authorities-search-for-fani-willis-lover-after-missing-house-judiciary-committee-hearing/?utm_source=truthpress.beehiiv.com&

Investor2014

Investor2014 5 minutes ago

If KarXT becomes Standard of Care (SoC), then a confirmatory trial with A3-71 in Schizophrenia would almost certainly allow SoC co-administration. Given that will also apply to the placebo cohort, the trial would be measuring any differential efficacy resulting from A3-71. Of course, as is always th

antihama

antihama 6 minutes ago

Thanks for the example. Interesting.

bull runs

bull runs 7 minutes ago

“Klug will be dead before they exhaust all their options.” Again is this a threat? By the way how is my question off topic? Your stand alone statement makes no reference to age whatsoever. Sounds like a threat to me.

make it happen

make it happen 7 minutes ago

I feel this should 10x. Aapl 3.5 trilion vs VZ 0.18 t

tw0122

tw0122 8 minutes ago

Resistance at .87 by any chance breaches it could see a quick 1.20 followed by a big dilution dump

ChannelTrader

ChannelTrader 8 minutes ago

Methinks

Methinks 9 minutes ago

https://techinformed.com/bt-group-detects-200-million-daily-cyber-threats-enhances-security-with-quantum-encryption/
AI, quantum - just get Wave.

PennyMillions852

PennyMillions852 10 minutes ago

So let’s send it! Above a penny is where it needs to be for starters!

burner67

burner67 10 minutes ago

Funny how anyone with an opinion different than you longs ‘has nothing better to do’. My guess is shareholders spends much more time here than any bear.

ChristianSmart

ChristianSmart 10 minutes ago

tw0122

tw0122 11 minutes ago

ONCO 6.20s-6.40s resistance zone 1 out 80% out of trade here next zone 6.80s much smaller chance

chklingon

chklingon 11 minutes ago

Meh, that has been hard to do, as most retail know what is coming over the next few years.

Methinks

Methinks 12 minutes ago

https://therecord.media/cisa-warns-of-attacks-aginst-water-systems-arkansas-city
Take steps against all these attacks - use Wave.

Fdc4

Fdc4 13 minutes ago

I have been saying such as well, since the mentioned 20B Shares that will need to be injected accordingly. But everyone knows this is a long shot, the only reason of the hormones to be crazy now is due to “Audition” and “Name/Ticker” change. That’s it

Boiler_Master

Boiler_Master 13 minutes ago

You're probably right, I pulled a B in English 101 and a C in English 102 🤷‍♂️

I got a perfect score in Business 101 tho. In fact, I got an A in all my business and engineering classes.

Appreciate the grammar tips. Let me know if I can return the favor and help

nowwhat2

nowwhat2 13 minutes ago

So it just hit 66,000 there huh ?...... Food for thought ;

Dates are all over the map here so, I can understand how these could be confusing to some regardless
I'm going to display them anyways because they contain some important back-checkable info.

F

Methinks

Methinks 15 minutes ago

https://www.asiaone.com/asia/china-are-real-hackers-not-us-taiwan-says-after-cyber-accusations
Stop the accusations - use Wave.

TRUISM

TRUISM 15 minutes ago

PROTOTYPICAL INVENTIONS ARE BEST UTILISED WHEN A COMPANY IS FAIRLY

CERTAIN THERE IS ENOUGH MATERIAL TO PROVIDE FOR POTENTIATED MARKET

DEMAND.

Everyone’s focused on production while great development has been ongoing.

Saving Grace

Saving Grace 16 minutes ago

DALLAS, TX, Sept. 17, 2024 (GLOBE NEWSWIRE) -- NaturalShrimp, Inc. (OTCQB: SHMP) (the “Company” or “NSI”), a Biotechnology Aquaculture Company that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), today announced that, despite rece

Australian Clinical Labs

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions